There are 2 types of Predictive genetic testing : pre-symptomatic (eventual development of symptoms is certain when the gene mutation is present, e.g., Huntington disease) and pre-dispositional (eventual development of symptoms is likely but not certain when the gene mutation is present, e.g., breast cancer). These types of testing are used to detect gene mutations associated with disorders that appear after birth, often later in life. These tests can be helpful to people who have a family member with a genetic disorder, but who have no features of the disorder themselves at the time of testing. The results of predictive testing can provide information about a person’s risk of developing a specific disorder and help with making decisions about medical care.
Cancer Genetic Tests
Diabetes is a group of not well-understood disorders characterized by abnormal glucose levels. As a complex disease, diabetes is the result of the interplay between the individual’s genetic make-up and the environment and there are multiple genes that are known to be associated with this condition; thus, a multigene panel represents a cost-effective option to identify the genetic cause of diabetes.
The Heart Panel is a comprehensive 133 genetic diagnostic tool developed to cover a wide spectrum of cardiomyopathy and channelopathy diagnostics. Typically there is a difficulty to distinguish between the cardiomyopathy and channelopathy conditions and on some occasions the patient can actually have both. The Heart Panel provides a high-quality readout of all clinically relevant genes associated with both conditions. The OS-Seq™ technology provides high coverage clinical grade sequencing and enables reliable diagnostics for patients with significantly lower costs and faster turnaround time.
Note: Additional charges will apply for Deletion/Duplication Analysis
Non-Invasive Prenatal Test (NIPT)
Prenatal test is the most broadly studied cell-free DNA-based maternal blood test. Clinical studies have been done in more than 22,000 women of all ages and over 400,000 pregnancies tested worldwide. It is a new option in prenatal screening. The screening test can be done as early as 10 Weeks of pregnancy.
Protected: Parkinson-Alzheimer-Dementia NGS Panel (38 GENE PANEL)
Parkinson-Alzheimer-Dementia NGS Panel (38 GENE PANEL)